Related Experiment Video
Updated: Aug 12, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Seroconversion, seroreversion, and serowaffling among participants initiating antiretroviral therapy in Project
Joanne D Stekler1,2,3, Lauren R Violette1,3, Lisa A Niemann1
1Department of Medicine, University of Washington, Seattle, WA, USA.
Insights
Incomplete HIV seroconversion and seroreversion are increasingly recognized issues in testing programs. Oral fluid tests may be more prone to false negatives, impacting HIV diagnosis and treatment.
Area of Science:
- Infectious Diseases
- Public Health
- Diagnostic Testing
Background:
- Incomplete HIV seroconversion and seroreversion are increasingly documented in HIV testing and pre-exposure prophylaxis (PrEP) programs.
- These phenomena pose challenges for accurate HIV diagnosis and monitoring, particularly in individuals on antiretroviral treatment.
- Understanding the nuances of these testing discrepancies is crucial for effective HIV prevention and care strategies.
Purpose of the Study:
- To analyze incomplete seroconversion and seroreversion patterns based on specimen and test type.
- To investigate the frequency of seroreversion and "serowaffling" (fluctuating test results) in a longitudinal study.
- To explore potential associations between Fiebig stage at antiretroviral therapy (ART) initiation and seroconversion outcomes.
Main Methods:
- Utilized data from Project DETECT, a longitudinal study involving point-of-care HIV tests.
- Defined "incomplete seroconversion" as persistent nonreactive tests at study censoring.
- Defined "seroreversion" as regression to nonreactive after a reactive result, and "serowaffling" as reactive-nonreactive-reactive results.
- Employed Fisher's exact tests to examine relationships between Fiebig stage and seroconversion outcomes.
Main Results:
- Ten out of 1940 participants exhibited incomplete seroconversion, with eight showing seroreversion.
- Incomplete seroconversion with persistent nonreactive results was observed exclusively with oral fluid (OF) tests.
- Seroreversion of OF tests occurred in six participants; two participants showed seroreversion in fingerstick and venipuncture tests.
- Serowaffling was observed in 45% of participants (nine individuals).
- No significant associations were found between Fiebig stage at ART initiation and the observed seroconversion patterns.
Conclusions:
- Oral fluid HIV tests may be particularly susceptible to false-negative results, contributing to incomplete seroconversion.
- Seroreversion and incomplete seroconversion in individuals on ART represent a growing concern for HIV testing and treatment programs.
- Further research is needed to refine HIV testing strategies and address discrepancies in individuals undergoing treatment.
Background:
Incomplete HIV seroconversion and seroreversion are increasingly documented by testing and pre-exposure prophylaxis programs more than previously recognized. This analysis reports on incomplete seroconversion and seroreversion by specimen and test type among Project DETECT participants.
Methods:
Project DETECT included a longitudinal study of point-of-care tests. Participants were categorized as having "incomplete seroconversion" if all timepoints had ≥1 nonreactive test at study censoring. Among participants with incomplete seroconversion, we defined "seroreversion" as sustained regression to nonreactive for any test following a reactive result. We define "serowaffling" as any reactive result followed by a nonreactive and then reactive result. We used Fisher's exact tests to explore relationships between Fiebig stage at ART initiation and incomplete seroconversion, seroreversion, and serowaffling.
Results:
Twenty of 1940 Project DETECT participants met criteria for this subset. Ten participants had complete seroconversion after a median of 23 (IQR 16-47) days following initial positive tests. Ten participants had incomplete seroconversion, eight of whom had seroreversion. Incomplete seroconversion with persistent nonreactive tests was seen only with oral fluid (OF). Of eight participants with seroreversion, all experienced seroreversion of OF tests if the test was ever reactive (n = 6); seroreversion occurred in fingerstick and venipuncture tests in two participants. Serowaffling occurred in nine (45%) participants. No associations were seen between Fiebig stage at ART start and complete seroconversion, seroregression, or serowaffling in our sample.
Conclusions:
OF tests may be particularly susceptible to providing false-negative results. Seroreversion and incomplete seroconversion among individuals on antiretroviral treatment may represent a growing problem for HIV testing and treatment programs.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Retroviruses

